🇺🇸 미국주식 도서
박종훈의 미국주식투자 레시피 : 경제뉴스 꿀조합과 투자…
18,000원
최소한의 주식투자:ETF부터 코스피·미국 주식까지 평생…
19,800원
박종훈의 미국주식투자 레시피:월가의 정보를 수익으로 바…로켓
18,000원
이 포스팅은 쿠팡 파트너스 활동의 일환으로, 이에 따른 일정액의 수수료를 제공받습니다.
| 항목 | 2024-06 | 2024-09 | 2024-12 | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $22.45B | $22.47B | $88.82B | $21.89B | $23.74B | $23.99B | $94.19B | $24.06B |
| Net Income | $4.69B | $2.69B | $14.07B | $11.00B | $5.54B | $5.15B | $26.80B | $5.24B |
| EPS (Diluted) | $1.93 | $1.11 | $5.79 | $4.54 | $2.29 | $2.12 | $11.03 | $2.14 |
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospita...
🔗 emfls.com 다른 콘텐츠 보기